119 related articles for article (PubMed ID: 10697303)
21. Activation of the sodium-potassium pump contributes to insulin-induced vasodilation in humans.
Tack CJ; Lutterman JA; Vervoort G; Thien T; Smits P
Hypertension; 1996 Sep; 28(3):426-32. PubMed ID: 8794828
[TBL] [Abstract][Full Text] [Related]
22. Biphasic effect of epinephrine on blood glucose during hyperinsulinemia in borderline hypertensive young men.
Høieggen A; Fossum E; Moan A; Rostrup M; Eide IK; Kjeldsen SE
Am J Hypertens; 2001 Jun; 14(6 Pt 1):539-45. PubMed ID: 11411733
[TBL] [Abstract][Full Text] [Related]
23. Neurovascular and hemodynamic responses to hyperinsulinemia in healthy postmenopausal women.
Cardoso CG; Sakai D; Pinto LG; Labes E; de Gusmão JL; Abrahão SB; Tinucci T; Mion D; da Fonseca AM; Forjaz CL
Maturitas; 2007 Sep; 58(1):50-8. PubMed ID: 17580104
[TBL] [Abstract][Full Text] [Related]
24. How reproducible is bilateral forearm plethysmography?
Petrie JR; Ueda S; Morris AD; Murray LS; Elliott HL; Connell JM
Br J Clin Pharmacol; 1998 Feb; 45(2):131-9. PubMed ID: 9491825
[TBL] [Abstract][Full Text] [Related]
25. Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia.
Eid HM; Reims H; Arnesen H; Kjeldsen SE; Lyberg T; Seljeflot I
Metabolism; 2007 Apr; 56(4):464-9. PubMed ID: 17379002
[TBL] [Abstract][Full Text] [Related]
26. Effect of the alpha-adrenergic blocker, doxazosin, on endothelial function and insulin action.
Courtney CH; McCance DR; Atkinson AB; Bassett J; Ennis CN; Sheridan B; Bell PM
Metabolism; 2003 Sep; 52(9):1147-52. PubMed ID: 14506621
[TBL] [Abstract][Full Text] [Related]
27. Vasodilator response to systemic but not to local hyperinsulinemia in the human forearm.
Cardillo C; Kilcoyne CM; Nambi SS; Cannon RO; Quon MJ; Panza JA
Hypertension; 1998 Oct; 32(4):740-5. PubMed ID: 9774373
[TBL] [Abstract][Full Text] [Related]
28. Acute angiotensin II receptor blockade improves insulin-induced microvascular function in hypertensive individuals.
Jonk AM; Houben AJ; Schaper NC; de Leeuw PW; Serné EH; Smulders YM; Stehouwer CD
Microvasc Res; 2011 Jul; 82(1):77-83. PubMed ID: 21514308
[TBL] [Abstract][Full Text] [Related]
29. Alterations in angiotensin II release and vascular reactivity in hypertensive men: a pilot study.
Gasic S; Ratheiser K; Wagner O; Nowotny P; Vierhapper H; Waldhäusl W
Am J Hypertens; 1999 Nov; 12(11 Pt 1):1055-62. PubMed ID: 10604480
[TBL] [Abstract][Full Text] [Related]
30. Dissociation between insulin sensitivity of glucose uptake and endothelial function in normal subjects.
Utriainen T; Mäkimattila S; Virkamäki A; Bergholm R; Yki-Järvinen H
Diabetologia; 1996 Dec; 39(12):1477-82. PubMed ID: 8960829
[TBL] [Abstract][Full Text] [Related]
31. Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo.
Clerk LH; Rattigan S; Clark MG
Diabetes; 2002 Apr; 51(4):1138-45. PubMed ID: 11916937
[TBL] [Abstract][Full Text] [Related]
32. Ageing impairs insulin-mediated vasodilatation but not forearm glucose uptake.
Lind L; Fugmann A; Millgård J; Berne C; Lithell H
Eur J Clin Invest; 2001 Oct; 31(10):860-4. PubMed ID: 11737223
[TBL] [Abstract][Full Text] [Related]
33. Contrasting effects of L-arginine on insulin-mediated blood flow and glucose disposal in the elderly.
Meneilly GS; Battistini B; Floras JS
Metabolism; 2001 Feb; 50(2):194-9. PubMed ID: 11229429
[TBL] [Abstract][Full Text] [Related]
34. C-peptide has no effect on forearm blood flow during local hyperinsulinaemia in healthy humans.
Langenberger H; Schaller G; Pleiner J; Mittermayer F; Bayerle-Eder M; Wolzt M
Br J Clin Pharmacol; 2003 Jun; 55(6):526-30. PubMed ID: 12814445
[TBL] [Abstract][Full Text] [Related]
35. Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.
Fernandez M; Triplitt C; Wajcberg E; Sriwijilkamol AA; Musi N; Cusi K; DeFronzo R; Cersosimo E
Diabetes Care; 2008 Jan; 31(1):121-7. PubMed ID: 17909084
[TBL] [Abstract][Full Text] [Related]
36. Intravenous AICAR during hyperinsulinemia induces systemic hemodynamic changes but has no local metabolic effect.
Bosselaar M; Smits P; van Loon LJ; Tack CJ
J Clin Pharmacol; 2011 Oct; 51(10):1449-58. PubMed ID: 21148051
[TBL] [Abstract][Full Text] [Related]
37. Increase in systolic blood pressure and catecholamine level during hyperinsulinemia in a placebo-controlled euglycemic clamp in healthy subjects.
Kern W; Fittje A; Fohr W; Kerner W; Born J; Fehm HL
Exp Clin Endocrinol Diabetes; 2000; 108(8):498-505. PubMed ID: 11149624
[TBL] [Abstract][Full Text] [Related]
38. Direct vasodilator effects of physiological hyperinsulin-aemia in human skeletal muscle.
Tack CJ; Schefman AE; Willems JL; Thien T; Lutterman JA; Smits P
Eur J Clin Invest; 1996 Sep; 26(9):772-8. PubMed ID: 8889439
[TBL] [Abstract][Full Text] [Related]
39. Seven days of euglycemic hyperinsulinemia induces insulin resistance for glucose metabolism but not hypertension, elevated catecholamine levels, or increased sodium retention in conscious normal rats.
Koopmans SJ; Ohman L; Haywood JR; Mandarino LJ; DeFronzo RA
Diabetes; 1997 Oct; 46(10):1572-8. PubMed ID: 9313752
[TBL] [Abstract][Full Text] [Related]
40. Moderate, Short-Term, Local Hyperglycemia Attenuates Forearm Endothelium-Dependent Vasodilation After Transient Ischemia-Reperfusion in Human Volunteers.
Ebert TJ; Novalija J; Barney JA; Uhrich TD; Arain SR; Freed JK; Pagel PS
J Cardiothorac Vasc Anesth; 2017 Oct; 31(5):1649-1655. PubMed ID: 28284926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
